China Universal Asset Management Company’s Lexeo Therapeutics LXEO Stock Holding History

China Universal Asset Management Company’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.2K	Sell	12,497 -455	-4%	-$2.46K	﹤0.01%	454
2026 Q1	$74.3K	Buy	12,952 +1,059	+9%	+$7.5K	0.01%	432
2025 Q4	$118K	Buy	11,893 +2,427	+26%	+$22.1K	0.01%	399
2025 Q3	$62.9K	Buy	9,466 +2,799	+42%	+$13.5K	0.01%	415
2025 Q2	$26.8K	Buy	6,667 +35	+0.5%	+$115	﹤0.01%	442
2025 Q1	$23K	Sell	6,632 -379	-5%	-$1.68K	﹤0.01%	454
2024 Q4	$46.1K	Buy	+7,011	New	+$55.2K	﹤0.01%	453

Other funds holding LXEO

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

China Universal Asset Management Company's LXEO Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Lexeo Therapeutics (LXEO) stake by 3.5% in Q2 2026, selling an estimated $2.46K and leaving 12,497 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

China Universal Asset Management Company first reported a position in LXEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $118K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

China Universal Asset Management Company held 12,497 shares of Lexeo Therapeutics worth $58.2K as of Q2 2026.
China Universal Asset Management Company sold 455 Lexeo Therapeutics shares in Q2 2026, an estimated $2.46K.
Lexeo Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #454 holding.
China Universal Asset Management Company first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 7 quarters since.
China Universal Asset Management Company's Lexeo Therapeutics position peaked at $118K in Q4 2025.
141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.